Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly : For all, none, or which patients?
β Scribed by Felicetto Ferrara; Pellegrino Musto
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 76 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemiaβassociated antigens (LAA) as target structures might be a therapeutic option to enhance the graftβ__vs__.βleukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r
The management of acute myeloid leukemia in the elderly (65 years and older) is unsatisfactory because of poor patient tolerance of standard myeloablative chemotherapy. The authors conducted a Phase II study to evaluate the effectiveness and toxicity of 13-cis-retinoic acid (CRA) in the therapy of e
## Abstract Chromosomal integration of __human herpesvirus 6__ (HHVβ6) is a novel situation found in a small percentage of individuals. While active HHVβ6 infection is treatable using antivirals, the abnormally high level of HHVβ6 DNA found in chromosomal integration of HHVβ6 (CIβHHVβ6) is not affe